StockData
Avalyn Pharma Inc. logo

Avalyn Pharma Inc. (AVLN) stock

AVLNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$27.69−0.23 (-0.82%)

Close on Nov 18, 2026Market cap $1.23BP/E –Yield –

Avalyn Pharma operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$31.29M–
Q1 FY2026Mar 31, 2026-$27.91M–
Q2 FY2025Jun 30, 2025-$21.78M–
Q1 FY2025Mar 31, 2025-$18.72M–

More Avalyn Pharma figures

See a number that looks wrong?